Previous Close | 65.45 |
Open | 65.50 |
Bid | 66.20 x N/A |
Ask | 66.30 x N/A |
Day's Range | 65.20 - 66.70 |
52 Week Range | 40.32 - 67.75 |
Volume | |
Avg. Volume | 103,584 |
Market Cap | 6.359B |
Beta (5Y Monthly) | 1.37 |
PE Ratio (TTM) | 43.30 |
EPS (TTM) | 1.53 |
Earnings Date | Mar 23, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 09, 2019 |
1y Target Est | 62.80 |
Subscribe to Yahoo Finance Plus to view Fair Value for EVD.DE
South Korea-based immersive entertainment brand KAMP Global, in partnership with Eventim Live Asia (ELA), proudly present KAMP LA 2022. On October 15th and 16th, 2022, at the Rose Bowl Stadium, the most legendary venue in Los Angeles, KAMP LA 2022 will deliver one of the biggest live-music K-pop experiences in history.
Results driven by strong sepsis-focused instrument placements in the United StatesLEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial results for the first quarter ended March 31, 2022. Recent Highlights Achieved first quarter total revenue of $7.2 million, including product revenue of $3.8 million and research contribution reven
Company has Filed an Appeal and will Present a Plan to Regain ComplianceLEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that on May 5, 2022 it received a letter from The Nasdaq Stock Market informing the Company that its shares of common stock have failed to comply with the $1.00 minimum bid price required for continued listing on The Nasdaq Global Ma